The Center of BioModular Multi-Scale Systems for Precision Medicine (CBM2), located at the University of North Carolina-Chapel Hill, is a collaborative venture between UNC-Chapel Hill, Louisiana State University and Cornell Medical College. BME faculty member Steve Soper is the Director of CBM2. Dr. Soper is a Professor in the Joint BME Department, as well as a Professor in the Chemistry Department at UNC-Chapel Hill. CMB2 has been awarded a $6.3M NIH grant titled “Biotechnology Resource Center of Biomodular Multi-scale Systems (CBM2) for Precision Medicine” to embark upon an aggressive research program to generate new technology platforms for the molecular analysis of markers secured from circulation (i.e., blood). Markers include biological cells, cell free DNA, and exosomes as well as others. The molecular cargo they possess can be used to guide important clinical decisions for a number of important disease states. The Center leadership team will coordinate not only the research efforts of the Center, but also serve to evolve Collaborative and Service projects to allow integration of the Center’s discoveries with compelling biomedical and clinical applications. CBM2 touts excellence in micro/nanofabrication to generate tools for the analysis of genomes, proteomes, and pharmaceutical drugs. The Center, in conjunction with the Chapel Hill Analytical and Nanofabrication Laboratory (CHANL), contains state-of-the-art equipment for the fabrication of microstructures and nanostructures in a variety of materials over several different size domains. CBM2 also has expertise in fluidics, material characterization/modification, and assay development. Please see the CBM2 website for more information.